Full Text View
Tabular View
No Study Results Posted
Related Studies
Molecular Adsorbent Recirculating System (MARS) for Patients With Cirrhosis and Hepatic Encephalopathy
This study has been completed.
Study NCT00287235   Information provided by SCTI Research Foundation

First Received on February 2, 2006.   Last Updated on June 11, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hepatic Encephalopathy
Liver Failure
Hepatitis, Chronic
Liver Cirrhosis
Additional conditions recognized in this trial
Brain Damage, Chronic
Delirium
Encephalitis
Fibrosis
Hepatitis
Hepatitis A
Neurotoxicity Syndromes
More general conditions related to this trial
Brain Diseases
Brain Diseases, Metabolic
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Confusion
Delirium, Dementia, Amnestic, Cognitive Disorders
Digestive System Diseases
Enterovirus Infections
Hepatic Insufficiency
Hepatitis, Viral, Human
Liver Diseases
Mental Disorders
Metabolic Diseases
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Pathologic Processes
Picornaviridae Infections
Poisoning
RNA Virus Infections
Signs and Symptoms
Substance-Related Disorders
Virus Diseases
Sponsors listed in this trial
Tarek Hassanein
Sponsor of study was Teraklin, AG and Gambro, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services